| Over the past | Total investment | Would've become | Historic returns | Returns |
|---|---|---|---|---|
| 3 months | ₹15,000 | ₹14,715 | -1.90% | |
| 6 months | ₹30,000 | ₹30,811 | +2.70% | |
| 1 year | ₹60,000 | ₹66,321 | +10.54% | |
| 3 years | ₹1,80,000 | ₹2,16,770 | +20.43% |
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Repo | Unspecified | Repo | 26.57% |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | Equity | 9.69% |
| Divi's Laboratories Ltd. | Healthcare | Futures | 9.63% |
| Zydus Lifesciences Ltd | Healthcare | Equity | 9.39% |
| Glenmark Pharmaceuticals Limited | Healthcare | Futures | 9.34% |
| Strides Pharma Science Ltd | Healthcare | Equity | 9.04% |
| TORRENT PHARMACEUTICALS LTD^ | Healthcare | Futures | 8.62% |
| Pfizer Ltd | Healthcare | Equity | 7.37% |
| Glenmark Life Sciences Ltd | Healthcare | Equity | 6.21% |
| Ipca Laboratories Ltd | Healthcare | Equity | 5.98% |
| Aurobindo Pharma Ltd | Healthcare | Equity | 5.09% |
| Zydus Wellness Ltd | Consumer Staples | Equity | 4.90% |
| Aurobindo Pharma Ltd Futures | Healthcare | Futures | 4.52% |
| Colgate-Palmolive (India) Ltd | Consumer Staples | Equity | 3.45% |
| Natco Pharma Ltd | Healthcare | Equity | 3.01% |
| Dr. Reddy's Laboratories Ltd | Healthcare | Equity | 2.33% |
| Reserve Bank of India 91-D | Financial | Treasury Bills | 0.71% |
| GOVERNMENT OF INDIA 37693 091 DAYS TBILL 22OT26 FV RS 100 | Financial | Treasury Bills | 0.70% |
| GOVERNMENT OF INDIA 37816 091 DAYS TBILL 05NV26 FV RS 100 | Financial | Treasury Bills | 0.70% |
| GOVERNMENT OF INDIA 37846 091 DAYS TBILL 19NV26 FV RS 100 | Financial | Treasury Bills | 0.70% |
| GOVERNMENT OF INDIA 37861 091 DAYS TBILL 27NV26 FV RS 100 | Financial | Treasury Bills | 0.70% |
| 91 Days Treasury Bill 03-Dec-2026 | Financial | Treasury Bills | 0.70% |
| 91 DAYS TBILL RED 10-12-2026 | Financial | Treasury Bills | 0.70% |
| 91 DTB (17-DEC-2026) | Financial | Treasury Bills | 0.70% |
| 91 DTB (24-DEC-2026) | Financial | Treasury Bills | 0.70% |
| LG Electronics India Ltd. | Consumer Discretionary | Equity | 0.59% |
| Sumitomo Chemical India Ltd | Materials | Equity | 0.26% |
| Net Payables | Unspecified | Net Payables | -32.30% |
| Name | 6M | 1Y | 3Y | All |
|---|---|---|---|---|
| Fund returns | +17.5% | +14.3% | +20.1% | +20.7% |
| Category average (Equity Sectoral) | +16.2% | +12.9% | +21.2% | +17.1% |
| Rank (Equity Sectoral) | -- | 10 | 8 | -- |